Ultrastructural alterations of hepatic microbodies.
D000813:Anilides / Q000494:pharmacology; D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology; D001835:Body Weight; D006528:Carcinoma, Hepatocellular / Q000473:pathology; D007668:Kidney / Q000166:cytology; D008099:Liver / Q000166:cytology* / Q000187:drug effects; D008113:Liver Neoplasms; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D009929:Organ Size; D009940:Organoids / Q000187:drug effects* / Q000201:enzymology; D051381:Rats; D012459:Salicylates / Q000494:pharmacology
D000813:Anilides; D001565:Benzoates; D012459:Salicylates; D001241:Aspirin